Table 2.
Patient no | No of pp65 positive cells/2 × 105 leucocytes | HCMV DNA detected copy/ml |
---|---|---|
1 | 8 | 692 |
2. | 20 | 775 |
3 | 86 | 8462847 |
4 | 78 | 3817 |
5 | 13 | 15386 |
6 | 25 | 20201 |
7 | 28 | 1851 |
8 | 35 | 647 |
9 | 25 | 724 |
10 | 14 | 1673 |
11 | 32 | 29768 |
12 | 38 | 75479 |
13 | 35 | 500 |
14 | 48 | 460 |
15 | 78 | 271 |
16 | 20 | 775 |
17 | 86 | 8462847 |
18 | 78 | 3817 |
19 | 230 | 30902 |
20 | 8 | 692 |
21 | 49 | 674 |
22 | 35 | 4849 |
23 | 7 | 47 |
24 | 27 | 337 |
25 | 3 | 334 |
26 | 22 | 7456 |
27 | 15 | 1411 |
28 | 40 | 24104 |
29 | 52 | 6756 |
30 | 20 | 2265 |
31 | 7 | 4937 |
32 | 0 | 3079 |
33. | 32 | 29768 |
pp65 antigenemia assay and HCMV 2 × 105 leucocytes of peripheral blood and human cytomegalovirus DNA copy numbers detected/ml in the 33 renal transplant recipients who underwent valganciclovir treatment for symptomatic disease showed presence of antigenemia in 32/33 patients.